Skip to main content
. Author manuscript; available in PMC: 2021 Nov 11.
Published in final edited form as: J Biomed Inform. 2021 Apr 28;118:103795. doi: 10.1016/j.jbi.2021.103795

Table 2. Issues & Resolutions.

This table lists all of the noteworthy issues that required investigation and collaboration with the HL7® CG WG to resolve. The three columns show the issue label, category (Major, Minor) and resolution status (Clarification - GR IG or FHIR® solution, GR IG Change - CG WG modified GR IG to support, Workaround - extension or non-standard approach, Deferred - deferred workaround but submitted for future consideration). Detailed description for each of these issues is available on the Issues & Resolutions[25] page of the eMERGE FHIR® Specification’s website[26].

Issue Cat. Resolution
#1 Composite Reporting Major GR IG Change
#2 Nested Results Major Clarification
#3 Test Information Major Clarification
#4 Interpretation Summary Major Workaround
#5 Gene/Region Coverage Major Workaround
#6 Recommendations Major Clarification
#7 Secondary Findings Major Clarification
#8 Variant Data Types Major Deferred
#9 Report Comments Minor Clarification
#10 Confirmation Testing Major Workaround
#11 Pathogenicity Phenotypes Minor GR IG Change
#12 Pathogenicity Values Minor GR IG Change
#13 Report Category Minor GR IG Change
#14 Assessed Med Citations Major Workaround
#15 Sign-Out v Sent Date Minor Workaround
#16 Recommended Followup Reasons Minor Workaround
#17 Recommended Followup Codes Minor GR IG Change
#18 Disclaimers Major Workaround
#19 Patient Internal ID Minor Clarification
#20 Patient Age Major Workaround
#21 Research Flag Minor Deferred